000 01284 a2200361 4500
005 20250514052936.0
264 0 _c20030528
008 200305s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0704935
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohnatty, Sharon E
245 0 0 _aBeta 2 adrenergic receptor 5' haplotypes influence promoter activity.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cDec 2002
300 _a1213-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCell Line
650 0 4 _aHaplotypes
_xphysiology
650 0 4 _aHumans
650 0 4 _aLuciferases
_xgenetics
650 0 4 _aMutation
650 0 4 _aPolymorphism, Genetic
_xphysiology
650 0 4 _aPromoter Regions, Genetic
_xphysiology
650 0 4 _aReceptors, Adrenergic, beta-2
_xgenetics
650 0 4 _aStatistics, Nonparametric
650 0 4 _aTransfection
_xmethods
700 1 _aAbdellatif, Maha
700 1 _aShimmin, Lawrence
700 1 _aClark, Richard B
700 1 _aBoerwinkle, Eric
773 0 _tBritish journal of pharmacology
_gvol. 137
_gno. 8
_gp. 1213-6
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0704935
_zAvailable from publisher's website
999 _c12271520
_d12271520